3rd Generation Competitors

Alpha Generation manages and operates power generation facilities that are well positioned to provide reliable, secure, safe, and sustainable sources of power and meet the growing infrastructure needs created by electrification. This diverse portfolio of assets is owned by funds managed by ArcLight Capital Partners, LLC, a leading middle-market, value added infrastructure investment firm with strategic partnerships and investments across the power, renewables, strategic gas, battery storage, and transformative infrastructure sectors. AlphaGen is led by a deeply experienced senior management team with a proven track record of strategic, operational, and commercial expertise to help create value and manage risk. AlphaGen manages over 13,000 megawatts of power infrastructure across four RTO markets (PJM, NYISO, ISONE, and CAISO) and includes 21 generation facilities in 5 states.

We aim to provide cost-effective workspace solutions that meet your current business needs, with ease of scalability for your future growth, you can manage your day-to-day business operations in a professional working environment where you can build connections and partnerships. All your workspace needs are taken care of, so you can focus on your business,

Acute and critical care medicines help hospital staff save countless lives while under enormous pressure. Yet the space has seen precious little innovation for decades, leaving hospitals and patients at the mercy of outdated technologies. GENIXUS began in 2019 shortly after our founder visited the ICU with his two-week-old daughter and observed injections being administered with hand-written syringes. It seemed out of place in modern medicine. How, for instance, did they track the syringe? How could they be sure what was in it? And could quality be maintained? From his long experience in pharmaceutical and vaccine manufacturing, he knew there had to be a better way. The idea for GENIXUS was born: create a platform that brings together the brightest minds and latest innovations to reinvent how acute and critical care medicines are manufactured and delivered. Safeguarding what matters by bringing critical thinking to critical care.